CA2010058A1 - Storage of materials - Google Patents

Storage of materials

Info

Publication number
CA2010058A1
CA2010058A1 CA002010058A CA2010058A CA2010058A1 CA 2010058 A1 CA2010058 A1 CA 2010058A1 CA 002010058 A CA002010058 A CA 002010058A CA 2010058 A CA2010058 A CA 2010058A CA 2010058 A1 CA2010058 A1 CA 2010058A1
Authority
CA
Canada
Prior art keywords
materials
storage
storage stable
composition
swellable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002010058A
Other languages
French (fr)
Other versions
CA2010058C (en
Inventor
Felix Franks
Ross Henry Morris Hatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10651841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2010058(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2010058A1 publication Critical patent/CA2010058A1/en
Application granted granted Critical
Publication of CA2010058C publication Critical patent/CA2010058C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate

Abstract

A material or mixture of materials which is not itself storage stable is rendered storage stable by incorporation into a water-soluble or swellable glassy or rubbery composition which can then be stored at ambient temperature. Recovery is by adding aqueous solution to the composition.
CA002010058A 1989-02-16 1990-02-14 Storage of materials Expired - Lifetime CA2010058C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB89.03593.5 1989-02-16
GB898903593A GB8903593D0 (en) 1989-02-16 1989-02-16 Storage of materials

Publications (2)

Publication Number Publication Date
CA2010058A1 true CA2010058A1 (en) 1990-08-16
CA2010058C CA2010058C (en) 2007-11-06

Family

ID=10651841

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002010058A Expired - Lifetime CA2010058C (en) 1989-02-16 1990-02-14 Storage of materials

Country Status (8)

Country Link
US (2) US5098893A (en)
EP (1) EP0383569B1 (en)
JP (1) JP3068836B2 (en)
AU (1) AU622978B2 (en)
CA (1) CA2010058C (en)
DE (1) DE69008891T2 (en)
DK (1) DK0383569T3 (en)
GB (1) GB8903593D0 (en)

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US5958670A (en) * 1988-05-18 1999-09-28 Cobe Laboratories, Inc. Method of freezing cells and cell-like materials
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
IL90188A0 (en) * 1988-05-18 1989-12-15 Cryopharm Corp Process and medium for the lyophilization of erythrocytes
USRE38385E1 (en) * 1989-02-16 2004-01-13 Nektar Therapeutics Storage of materials
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
US5621094A (en) * 1990-05-14 1997-04-15 Quadrant Holdings Cambridge Limited Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sugar alcohol
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
GB9115153D0 (en) * 1991-07-12 1991-08-28 Patel Bipin C M Sol-gel composition for producing glassy coatings
GB9115154D0 (en) * 1991-07-12 1991-08-28 Patel Bipin C M Sol-gel composition for producing glassy coatings
US5250429A (en) * 1991-09-20 1993-10-05 Pharmacia P-L Biochemicals Inc. Glassified restriction enzymes
JPH07507443A (en) * 1992-01-21 1995-08-24 コーベ　ラボラトリーズ　インコーポレイテッド Methods of freezing cells and cell-like material
SE9201929D0 (en) * 1992-06-23 1992-06-23 Pharmacia Lkb Biotech METHOD AND SYSTEM FOR MOLECULAR-BIOLOGICAL DIAGNOSTICS
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6673335B1 (en) * 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US5792505A (en) * 1992-09-22 1998-08-11 Mccormick & Company, Inc. Flavor encapsulation
CA2145418A1 (en) * 1992-09-29 1994-04-14 John S. Patton Pulmonary delivery of active fragments of parathyroid hormone
US5599660A (en) * 1993-01-19 1997-02-04 Pharmacia Biotech Inc. Method and preparation for sequential delivery of wax-embedded, inactivated biological and chemical reagents
US7448375B2 (en) * 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
JPH08509018A (en) * 1993-04-16 1996-09-24 マコーミック アンド カンパニー，インク． Encapsulation composition
GB9308734D0 (en) * 1993-04-28 1993-06-09 Ici Plc Viable bacteria
JPH07191035A (en) 1993-11-17 1995-07-28 Toppan Printing Co Ltd Physiologically active material-immobilized sheet, its manufacture and preservation, and method for supplying physiologically active material using it
ES2218543T3 (en) 1994-03-07 2004-11-16 Nektar Therapeutics PROCEDURE AND PREPARATION FOR THE ADMINISTRATION OF INSULIN BY PULMONARY ROUTE.
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5955448A (en) * 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
JPH10500672A (en) * 1994-05-18 1998-01-20 インヘイル セラピューティック システムズ，インコーポレイティド Methods and compositions relating to dry powder formulations of interferon
DE69530196T2 (en) * 1994-06-02 2003-11-20 Elan Drug Delivery Ltd METHOD FOR PREVENTING THE AGGREGATION OF PROTEINS / PEPTIDES IN REHYDRATION OR THAWING
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
CZ297431B6 (en) 1994-08-04 2006-12-13 Quadrant Holdings Cambridge Limited Composition comprising solid dose delivery system for direct administration in solid form and process for its preparation
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US5565318A (en) * 1994-09-02 1996-10-15 Pharmacia Biotech, Inc. Room temperature stable reagent semi-spheres
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US6309671B1 (en) 1995-04-14 2001-10-30 Inhale Therapeutic Systems Stable glassy state powder formulations
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
GB9508691D0 (en) * 1995-04-28 1995-06-14 Pafra Ltd Stable compositions
US5756136A (en) * 1995-06-02 1998-05-26 Mccormick & Company, Inc. Controlled release encapsulation compositions
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
EP0758018B1 (en) * 1995-07-28 2004-06-09 Basf Aktiengesellschaft Salt-stabilized enzyme preparations
US6274369B1 (en) 1996-02-02 2001-08-14 Invitrogen Corporation Method capable of increasing competency of bacterial cell transformation
US5891692A (en) 1996-03-29 1999-04-06 Life Technologies, Inc. Method for increasing the viability and transformation ability of bacteria during or after storage at low temperatures
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
AU3214597A (en) 1996-05-29 1998-01-05 Universal Preservation Technologies, Inc. Long-term shelf preservation by vitrification
US5876992A (en) * 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
GB9619893D0 (en) * 1996-09-24 1996-11-06 Zeneca Ltd Novel composition
US6245366B1 (en) 1996-10-25 2001-06-12 Mccormick & Company, Inc. Fat-coated encapsulation compositions and method for preparing the same
FR2755440B1 (en) * 1996-11-07 1999-01-15 Tuffet Sophie METHOD FOR THE LONG-TERM PRESERVATION OF DNA MOLECULES AND PACKAGING FOR ITS IMPLEMENTATION
ID21635A (en) * 1996-12-20 1999-07-08 Astra Pharma Prod PHARMACEUTICAL COMPOSITION FOR FROZEN DRYING
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
EP1005529B1 (en) 1997-02-12 2005-04-27 Invitrogen Corporation Methods for lyophilizing competent cells
EP1005481B1 (en) 1997-04-22 2009-10-14 Life Technologies Corporation Methods for the production of aslv reverse transcriptases composed of multiple subunits
US5972395A (en) * 1997-04-25 1999-10-26 Kraft Foods, Inc. Method of preparing glass stabilized material
IL124275A (en) * 1997-05-02 2002-03-10 Bio Merieux Vitek Inc Method for generating nucleic acid sequences
US6558901B1 (en) 1997-05-02 2003-05-06 Biomerieux Vitek Nucleic acid assays
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
EP0913177A1 (en) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Process for producing dry, amorphous products comprising biological active materials by means of convection drying technique, especially spray drying
EP0913178A1 (en) * 1997-11-03 1999-05-06 Boehringer Mannheim Gmbh Process for the manufacture of dry, amorphous products comprising biologically active material by means of convection drying and products obtainable by the process
EP1032647B1 (en) * 1997-11-26 2006-03-29 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6444246B1 (en) 1997-12-16 2002-09-03 Mccormick & Company, Inc. Cake-resistant, hygroscopically sensitive materials and process for producing the same
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
WO1999055310A1 (en) 1998-04-27 1999-11-04 Altus Biologics Inc. Stabilized protein crystals, formulations containing them and methods of making them
CA2318604C (en) * 1998-01-20 2007-04-10 Grain Processing Corporation Reduced malto-oligosaccharides
US6919446B1 (en) 1998-01-20 2005-07-19 Grain Processing Corp. Reduced malto-oligosaccharides
ES2248902T3 (en) * 1998-05-06 2006-03-16 Societe Imagene LONG-TERM CONSERVATION PROCEDURE OF DNA MOLECULES AND PACKING FOR CARRYING OUT.
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
DE69939059D1 (en) * 1998-05-13 2008-08-21 Novozymes Inc PROCESS FOR USE OF CELLOBIOSEDEHYDROGENASE IN BAKING
EP1027886B1 (en) * 1999-02-10 2008-07-09 Pfizer Products Inc. Pharmaceutical solid dispersions
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
ATE555773T1 (en) * 1999-06-09 2012-05-15 Sievers Robert E SUPERCRITICAL FLUID-ASSISTED NEBULIZATION AND BUBBLES DRYING
NL1012300C2 (en) * 1999-06-11 2000-12-12 Rijksuniversiteit Stabilizer for pharmaceuticals.
US6380379B1 (en) 1999-08-20 2002-04-30 Grain Processing Corporation Derivatized reduced malto-oligosaccharides
WO2001028325A2 (en) 1999-10-20 2001-04-26 Grain Processing Corporation Compositions including reduced malto-oligosaccharide preserving agents
BR0007202A (en) 1999-10-20 2005-04-12 Grain Processing Corp Reduced maltooligosaccharide cleaning compositions
WO2001036454A1 (en) 1999-11-18 2001-05-25 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
US6890896B1 (en) 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
ATE524163T1 (en) † 2000-04-10 2011-09-15 Teva Pharma STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING 7-SUBSTITUTED-3,5-DIHYDROXYHEPTENOIC ACIDS OR 7-SUBSTITUTED-3,5-DIHYDROXYHEPTENOIC ACIDS
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
ES2525087T5 (en) 2000-05-10 2018-06-28 Novartis Ag Phospholipid-based powders for drug administration
EP2295551B1 (en) 2000-05-26 2016-04-06 Life Technologies Corporation Thermostable reverse transcriptases and uses thereof
US7575761B2 (en) * 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
WO2002009674A2 (en) * 2000-07-28 2002-02-07 Inhale Therapeutic Systems, Inc. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
DE50012114D1 (en) 2000-09-05 2006-04-13 Zeltz Patrick Method for the specific determination of DNA sequences by means of parallel amplification
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AU2002248192A1 (en) * 2000-12-15 2002-08-12 Stratagene Room temperature stable competent cells
US6623762B2 (en) 2001-02-16 2003-09-23 Cambridge Biostability Ltd. Composition and method for controlled release injections
EP1401862A4 (en) * 2001-05-17 2004-12-15 Ceremedix Inc Peptide compounds for counteracting reactive oxygen species and free radicals
AU2002331847A1 (en) * 2001-09-14 2003-04-01 Invitrogen Corporation Composition for stabilizing biological materials
ES2364636T3 (en) 2001-12-19 2011-09-08 Novartis Ag PULMONARY ADMINISTRATION OF AMINOGLUCOSIDS.
CN100592903C (en) * 2002-04-03 2010-03-03 索尔瓦药物有限公司 Stabilized natural cannabinoid formulation and preparation method thereof
UA79281C2 (en) * 2002-04-03 2007-06-11 Solvay Pharm Bv Stabilized composition comprising a natural cannabinoid compound and process for the preparation thereof
CA2849556A1 (en) * 2002-04-11 2003-10-23 Vu Truong-Le Preservation of bioactive materials by freeze dried foam
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
DE10234165B4 (en) * 2002-07-26 2008-01-03 Advanced Micro Devices, Inc., Sunnyvale A method of filling a trench formed in a substrate with an insulating material
EP1554377B1 (en) 2002-09-13 2012-11-07 Life Technologies Corporation Thermostable reverse transcriptases and uses thereof
US6927062B2 (en) * 2002-11-25 2005-08-09 Agdia, Inc. Controls and standards for assays and method for manufacture thereof
CA2523475C (en) * 2003-05-28 2013-02-05 Nektar Therapeutics Pharmaceutical formulation comprising a water-insoluble active agent
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
SG135204A1 (en) * 2003-07-18 2007-09-28 Baxter Int Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
EP1646354A4 (en) * 2003-07-22 2010-03-17 Baxter Int Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060099567A1 (en) * 2004-04-08 2006-05-11 Biomatrica, Inc. Integration of sample storage and sample management for life science
SG151298A1 (en) 2004-04-08 2009-04-30 Biomatrica Inc Integration of sample storage and sample management for life science
US20060039985A1 (en) * 2004-04-27 2006-02-23 Bennett David B Methotrexate compositions
WO2005112893A1 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
CN103432079A (en) 2004-05-12 2013-12-11 巴克斯特国际公司 Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
US7815941B2 (en) * 2004-05-12 2010-10-19 Baxter Healthcare S.A. Nucleic acid microspheres, production and delivery thereof
WO2006014930A2 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
CN105168146A (en) 2006-08-04 2015-12-23 巴克斯特国际公司 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
CN104774924B (en) * 2006-09-18 2021-04-13 通用电气医疗集团生物科学公司 Preparation of glass-coated biological reagents
DE102006056790B3 (en) * 2006-12-01 2008-01-17 IfP Privates Institut für Produktqualität GmbH Kit for carrying out a polymerase chain reaction comprises reaction vessels loaded by drying aqueous solutions of the reagents in the presence of trehalose alone
US7738094B2 (en) 2007-01-26 2010-06-15 Becton, Dickinson And Company Method, system, and compositions for cell counting and analysis
US7816135B2 (en) 2007-07-05 2010-10-19 Becton, Dickinson And Company Method of analyzing lymphocytes
US8367427B2 (en) 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
JP5969731B2 (en) * 2008-10-17 2016-08-17 国立大学法人東京海洋大学 Reagent kit for freshness measurement
CA2688174C (en) 2008-12-19 2018-08-07 F. Hoffmann-La Roche Ag Dry composition of reaction compounds with stabilized polymerase
KR101976107B1 (en) 2009-05-29 2019-05-09 펄 테라퓨틱스 인코포레이티드 Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP2440658B1 (en) 2009-06-12 2014-10-08 Micronics, Inc. Rehydratable matrices for dry storage of taq polymerase in a microfluidic device
CN102803507B (en) 2009-06-12 2016-05-25 精密公司 The composition and the method that store in the dehydration of plate reactant for microfluidic device
CN102725406B (en) * 2009-12-29 2016-06-01 通用电气医疗集团生物科学公司 The improvement of Nucleic Acid Elution
RU2588658C2 (en) 2010-04-27 2016-07-10 ЭсСиАйЭл Текнолоджи ГмбХ Stable aqueous compositions of protein mia/cd-rap
US9845489B2 (en) 2010-07-26 2017-12-19 Biomatrica, Inc. Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
JP5933544B2 (en) 2010-07-26 2016-06-08 バイオマトリカ， インコーポレーテッド Compositions for stabilizing blood DNA, RNA and proteins and other biological samples shipped and stored at ambient temperature
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
CN103946704B (en) 2011-08-26 2017-11-24 艾维亚纳分子技术有限公司 The biological application type piezoelectric biological sensor platform used for point of care diagnostics
JP6339578B2 (en) 2012-10-31 2018-06-06 タケダ・ゲー・エム・ベー・ハーＴａｋｅｄａ ＧｍｂＨ Lyophilized preparation containing GM-CSF neutralizing compound
AR093297A1 (en) 2012-10-31 2015-05-27 Amgen Res (Munich) Gmbh LIQUID FORMULATION THAT INCLUDES A GM-CSF NEUTRALIZING COMPOUND
WO2014100755A2 (en) 2012-12-20 2014-06-26 Biomatrica, Inc. Formulations and methods for stabilizing pcr reagents
RU2696582C2 (en) 2013-03-15 2019-08-05 Перл Терапьютикс, Инк. Methods and systems for conditioning disperse crystalline materials
AU2014268482A1 (en) 2013-05-22 2016-01-07 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of three or more active agents
CA2912307C (en) * 2013-06-11 2022-01-11 Biocartis Nv Biomolecule drying process for long-term storage
KR20220045064A (en) 2013-08-30 2022-04-12 다케다 야쿠힌 고교 가부시키가이샤 Antibodies neutralizing gm-csf for use in the treatment of rheumatoid arthritis or as analgesics
US9663770B2 (en) 2014-01-22 2017-05-30 Life Technologies Corporation Reverse transcriptases for use in high temperature nucleic acid synthesis
CA2946230A1 (en) 2014-05-07 2015-11-12 Takeda Gmbh Liquid formulation comprising gm-csf neutralizing compound
ES2786373T3 (en) 2014-06-10 2020-10-09 Biomatrica Inc Platelet stabilization at room temperatures
EP3387411B1 (en) 2015-12-08 2023-05-10 Biomatrica, INC. Reduction of erythrocyte sedimentation rate
JP6965367B2 (en) 2017-05-19 2021-11-10 ジェン−プローブ・インコーポレーテッド Dry composition containing flap endonuclease
CA3226155A1 (en) 2021-07-09 2023-01-12 Astrazeneca Pharmaceuticals Lp Compositions, methods and systems for aerosol drug delivery
WO2023119093A1 (en) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, methods and systems for aerosol drug delivery
WO2023212191A1 (en) 2022-04-28 2023-11-02 Astrazeneca Ab Combination of albuterol and budesonide for the treatment of asthma

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US586504A (en) * 1897-07-13 Otto marcsch
DE159826C (en) *
US125714A (en) * 1872-04-16 Improvement in medical compounds or phosphated candies
US1855591A (en) 1926-02-03 1932-04-26 Wallerstein Co Inc Invertase preparation and method of making the same
US2457036A (en) 1946-04-10 1948-12-21 Albert A Epstein Coffee concentrate and the process of producing it
US2648609A (en) * 1949-01-21 1953-08-11 Wisconsin Alumni Res Found Method of applying coatings to edible tablets or the like
US3300474A (en) * 1964-02-12 1967-01-24 Pharmacia Ab Sucrose ether copolymerizates
DE1216486B (en) * 1964-04-23 1966-05-12 Merck Ag E Process for the production of coated tablets
DE1482489A1 (en) * 1965-01-13 1970-03-12 Boehringer Mannheim Gmbh Fully automatic coating process
NL6601426A (en) * 1965-02-12 1966-08-15
US3413198A (en) * 1966-06-30 1968-11-26 Calbiochem Reagents and method for assaying biological samples
LU62030A1 (en) * 1970-11-10 1972-07-26
US4157386A (en) * 1978-05-18 1979-06-05 Rochelle Paul J Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing
JPS5597096A (en) 1979-01-12 1980-07-23 Nec Corp High-speed mos driving circuit
DE3066710D1 (en) * 1979-10-17 1984-03-29 Roquette Freres Process for hard coating with sorbitol
EP0111216A3 (en) 1980-03-31 1985-01-16 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
US4372942A (en) * 1981-08-13 1983-02-08 Beecham Inc. Candy base and liquid center hard candy made therefrom
US4743554A (en) * 1981-09-08 1988-05-10 Boothroyd John C Recombinant DNA expression vector encoding for foot and mouth disease virus proteins
JPS5858146A (en) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd Microcapsule with fast releasability and preparation thereof
US4457916A (en) 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
JPS6035263A (en) 1983-08-05 1985-02-23 Wako Pure Chem Ind Ltd Stabilization of immunologically active substance immobilized on non-soluble carrier and physiologically active substance measuring reagent containing the same as composition unit
GB8323094D0 (en) * 1983-08-26 1983-09-28 Franks F Preservation of cells
GB2146531B (en) * 1983-09-15 1987-04-29 Stc Plc Controlled release system
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
JPS60258125A (en) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc Water-soluble dried material containing proteinic physiologically active substance
FI78117C (en) * 1984-06-25 1989-06-12 Suomen Sokeri Oy Process for preparing a stable glucose isomerase concentrate
GB8500698D0 (en) 1985-01-11 1985-02-13 Unilever Plc Preparation of reagents
US4594380A (en) * 1985-05-01 1986-06-10 At&T Bell Laboratories Elastomeric controlled release formulation and article comprising same
DE229810T1 (en) * 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire, Gb PROTECTION OF PROTEINS AND SIMILAR.
GB8517663D0 (en) * 1985-07-12 1985-09-18 Living Images Ltd Display unit
DE3541186A1 (en) * 1985-11-21 1987-05-27 Boehringer Mannheim Gmbh WATER-SOLUBLE, STABILIZED PEROXIDASE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE FOR DETERMINING HYDROGEN PEROXIDE
GB8604983D0 (en) 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
DE3614838A1 (en) * 1986-05-02 1987-11-12 Boehringer Mannheim Gmbh STABILIZED NAD (P) H-DEPENDENT SOLUBLE NITRATE REDUCTASE METHOD FOR THE PRODUCTION AND USE THEREOF
US4741872A (en) * 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
JPH0826345B2 (en) * 1986-07-10 1996-03-13 株式会社林原生物化学研究所 Method for producing solid oil-soluble substance
US5155024A (en) * 1986-07-10 1992-10-13 Eastman Kodak Company Binder composition and analytical element having stabilized peroxidase in layer containing the composition
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
JP2562624B2 (en) * 1986-11-07 1996-12-11 昭和電工株式会社 Water-soluble microcapsule and liquid detergent composition
US4847090A (en) * 1986-11-07 1989-07-11 Warner-Lambert Company Confection product and method for making same
US4753790A (en) * 1986-12-16 1988-06-28 Warner-Lambert Company Sorbitol coated comestible and method of preparation
CH674370A5 (en) * 1987-03-27 1990-05-31 Pier Luigi Prof Dr Luisi
FR2613619B1 (en) * 1987-04-07 1993-10-15 Recherche Informatique Pharmacie DRUGS, DIETETIC PRODUCTS OR HYGIENE PRODUCTS IN THE FORM OF POWDER COMPOSITIONS OBTAINED BY ADSORPTION OF ACTIVE INGREDIENTS ON A FAST-DISSOLVING SUGAR
US4873085A (en) * 1987-04-20 1989-10-10 Fuisz Pharmaceutical Ltd. Spun fibrous cosmetic and method of use
GB8715238D0 (en) 1987-06-29 1987-08-05 Quadrant Bioresources Ltd Food process
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
GB8801338D0 (en) 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
GB8826429D0 (en) 1988-11-11 1988-12-14 Univ Leeds Ind Service Ltd Enzyme stabilisation systems
US4963359A (en) * 1989-01-30 1990-10-16 Plough, Inc. Non-cariogenic confections
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
AU659645B2 (en) 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
JP3146400B2 (en) * 1993-06-24 2001-03-12 日清紡績株式会社 Cable connection method for drum brake

Also Published As

Publication number Publication date
DE69008891D1 (en) 1994-06-23
AU622978B2 (en) 1992-04-30
CA2010058C (en) 2007-11-06
USRE37872E1 (en) 2002-10-08
JPH02265984A (en) 1990-10-30
EP0383569A2 (en) 1990-08-22
EP0383569A3 (en) 1990-11-22
AU4924490A (en) 1990-08-30
JP3068836B2 (en) 2000-07-24
DE69008891T2 (en) 1994-11-03
EP0383569B1 (en) 1994-05-18
DK0383569T3 (en) 1994-09-05
GB8903593D0 (en) 1989-04-05
US5098893A (en) 1992-03-24

Similar Documents

Publication Publication Date Title
CA2010058A1 (en) Storage of materials
EP0906951A3 (en) Storage of materials
IE812075L (en) Composition
AU587268B2 (en) Detergent foam control agents
DK0390435T3 (en) Mixture containing a compound of the vitamin B group, and preparation thereof
CA2001552A1 (en) Cyclophosphamide - sodium bicarbonate lyophilizates
JPS547463A (en) Caulking composition
EP0309227A3 (en) Heat storage chemical mixtures
JPS53129242A (en) Chlorine-containing resin composition
AU4577689A (en) Sustained release compositions using as matrix hemicellulose extracted from wheat bran
IL49742A (en) Insect repellent compositions containing a halobenzoylpropionic acid ester and n,n-diethyl-m-toluamide
AU2115388A (en) Anilinophenylthioureas, anilinophenylcarbodiimides, anilinophenylisothioureas, salts thereof with organic and inorganic acids, their preparation and intermediates for their preparation, compositions containing them, and use thereof in pest control
JPS53135925A (en) Decomposition of microbial cells
JPS53110647A (en) Improvement of water resistance of polyvinyl alcohol type polymer
AU572696B2 (en) Saline-water compatible surfactant with a flash point above 50 degrees celcius
JPS52128288A (en) Glucose isomerase solution
JPS5625166A (en) 5-fluorouracil derivative
JPS5418897A (en) Polyisocyanate composition
JPS57140763A (en) Phenylsulfonamide derivative, its preparation, and agricultural and horticultural fungicide
JPS5367766A (en) Molded articles of chaff
JPS5742643A (en) 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol
JPS5767578A (en) N-phthtalidy-5-fluorouracil derivative
JPS5759889A (en) Novel piperidine derivative
JPS5461128A (en) Peptide derivative
JPS57180065A (en) Fluorescent lamp

Legal Events

Date Code Title Description
EEER Examination request
FZDC Discontinued application reinstated
MKEX Expiry